Density gradient liquid kit for myocardial cell isolation and purification and use method thereof

A density gradient, cardiomyocyte technology, applied in cell dissociation methods, animal cells, vertebrate cells, etc., can solve the problems of difficulty in taking into account purity and survival rate at the same time, affecting the survival rate of cardiomyocytes, increasing influencing factors, etc. Time-consuming purification, good separation effect, and high cell viability

Inactive Publication Date: 2018-06-15
XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The disadvantage of combined digestion with trypsin and collagenase is: trypsin has a certain damage to cardiomyocytes, which greatly affects the survival rate of cardiomyocytes. At present, although the contact time between cells and trypsin and the digestion time of trypsin are reduced as much as possible, but The effect on the survival rate of cardiomyocytes still exists, which is especially obvious in the process of isolation and purification of primary mouse myocardium
[0004] The disadvantage of using a single collagenase digestion is that although collagenase has a moderate effect and less damage to cells, it is necessary to use chemical inhibitors (such as 5-bromodeoxyuridine) to inhibit the growth of fibroblasts in order to purify the myocardium.
There are still defects such as low cell survival rate and low purity in the culture of primary mouse myocardial cells, and whether the presence of chemical inhibitors affects the function of cardiomyocytes remains to be proven, and the presence of chemical inhibitors will increase the impact of the experiment itself factors that can lead to unforeseen biases in the results
[0005] At the same time, the process of separation and purification of primary myocardial cells using the differential adherence method generally takes 3-3.5 hours, and the purity and survival rate are about 90%, and it is difficult to take into account the two aspects of purity and survival rate at the same time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Density gradient liquid kit for myocardial cell isolation and purification and use method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1: The process of carrying out cardiomyocyte separation and purification using the density gradient liquid kit for separation and purification of cardiomyocytes

[0040] A: Prepare:

[0041]1), put 75% alcohol in a 50ml centrifuge tube, autoclave instruments such as ophthalmic scissors and curved ophthalmic forceps, put them in the centrifuge tube for 20 minutes, and put them in a petri dish to air dry naturally; 40 suckling mice born within 3 days; 0.05 % type II collagenase 15ml, 0.1% type II collagenase 100ml; 10% fetal bovine serum (without penicillin and streptomycin) 100ml; fetal bovine serum 12ml; coating solution 100ml; three petri dishes; six-well plate, 15ml Several centrifuge tubes;

[0042] 2) Put gauze on the workbench;

[0043] 3) Place the cardiomyocyte culture medium in a water bath at 37°C.

[0044] B: Coating:

[0045] Add the prepared coating solution with a concentration of 1%-1.5% to the culture dish, incubate at 37°C for 1-2 hours, w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses a density gradient liquid kit for myocardial cell isolation and purification and a use method thereof, and relates to the technical field of biological cell culture. The kit includes a first reagent and a second reagent. The first reagent includes ultra pure water, Percoll liquid and a buffer solution in the volume ratio of 1:3:1; the second reagent includes ultra the pure water, the Percoll liquid and the buffer solution in the volume ratio of 2:2:1; the buffer solution of the first reagent and the second reagent includes 35.064-40.032 parts of NaCl, 1.975-2.013 parts of KCl, 0.615-1.107 parts of MgSO4 .7H2O, 4.865-5.226 parts of glucose, 0.301-0.384 parts of KH2PO4, 0.213-0.365 parts of Na2HPO4 and 23.830-29.788 parts of 4-hydroxyethylpiperazine ethane sulfonic acid.

Description

technical field [0001] The invention relates to the technical field of biological cell culture, in particular to a density gradient liquid kit for separating and purifying cardiomyocytes and a use method thereof. Background technique [0002] Various gene knockout and transgenic mice have been widely used in the establishment of animal models of cardiovascular diseases, and have made great contributions to the study of cardiovascular disease mechanisms. In vitro cardiomyocyte culture, as an in vitro experimental research model, can exclude the interference of nerves and body fluids and independently study the occurrence and development mechanisms of cardiovascular diseases at the cellular and molecular levels. Most of the current tool mice are from the mouse background, and cardiomyocytes The level of research mostly uses rat neonatal rat cardiomyocytes. Compared with the isolation and purification technology of rat myocardial primary cells and the relatively mature H9C2 cel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/077
CPCC12N5/0657C12N2509/00
Inventor 董念国刘保庆李飞尚小珂史峰邱雪峰史嘉玮陈思吴龙刘隽炜刘义华胡行健洪昊李华东孙永丰乔韡华李庚朱鹏李光周王怡轩刘发远谢飞刘名刘春耕黄玉明
Owner XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products